Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

BeauTop helps hair grow by increasing certain growth factors.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Social media can help compare the effectiveness and safety of new arthritis medications.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

New treatments focusing on immune pathways show promise for stubborn hair loss.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.